TypeSafe AI
Developer infrastructure that turns unstructured inputs into typed decisions and probability scores for automated software workflows.
$40MSeed
LeadD
DCVC
Activity from announced rounds
Activity in this selectionSeed
DCVC is an investment firm identified by TypeSafe AI as an existing investor and by its own communications as a backer of Shennon Biotechnologies.
Recorded funding activity
TypeSafe turns unstructured inputs into typed decisions and probability scores for automated software. Shennon develops T-cell engager therapies for solid tumors. Separate TypeSafe financings remain separate events under one investor history.
Sources
- Rounds participated in
- 2
- Confirmed lead rounds
- 1 1 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $140M 2 disclosed · full round size, not this investor’s share